Synopsys Net Worth
Synopsys Net Worth Breakdown | SNPS |
Synopsys Net Worth Analysis
Synopsys' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Synopsys' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Synopsys' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Synopsys' net worth analysis. One common approach is to calculate Synopsys' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Synopsys' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Synopsys' net worth. This approach calculates the present value of Synopsys' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Synopsys' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Synopsys' net worth. This involves comparing Synopsys' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Synopsys' net worth relative to its peers.
Enterprise Value |
|
To determine if Synopsys is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Synopsys' net worth research are outlined below:
Synopsys generated a negative expected return over the last 90 days | |
Synopsys is unlikely to experience financial distress in the next 2 years | |
Synopsys has a strong financial position based on the latest SEC filings | |
Over 91.0% of the company shares are owned by institutional investors | |
Latest headline from datacenterknowledge.com: Intel Names Chip Industry Veteran Tan as CEO |
Synopsys Quarterly Good Will |
|
Synopsys uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Synopsys. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Synopsys' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of February 2024 Upcoming Quarterly Report | View | |
15th of May 2024 Next Financial Report | View | |
31st of January 2024 Next Fiscal Quarter End | View | |
4th of December 2024 Next Fiscal Year End | View | |
31st of October 2023 Last Quarter Report | View | |
31st of October 2023 Last Financial Announcement | View |
Synopsys Target Price Consensus
Synopsys target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Synopsys' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
22 | Strong Buy |
Most Synopsys analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Synopsys stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Synopsys, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSynopsys Target Price Projection
Synopsys' current and average target prices are 446.23 and 634.37, respectively. The current price of Synopsys is the price at which Synopsys is currently trading. On the other hand, Synopsys' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Synopsys Market Quote on 17th of March 2025
Target Price
Analyst Consensus On Synopsys Target Price
Know Synopsys' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Synopsys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Synopsys backward and forwards among themselves. Synopsys' institutional investor refers to the entity that pools money to purchase Synopsys' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Pictet Asset Manangement Sa | 2024-12-31 | 1.8 M | Nuveen Asset Management, Llc | 2024-12-31 | 1.7 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.7 M | Northern Trust Corp | 2024-12-31 | 1.6 M | Van Eck Associates Corporation | 2024-12-31 | 1.5 M | Sustainable Growth Advisers, Lp | 2024-12-31 | 1.5 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 1.5 M | Swedbank Ab | 2024-12-31 | 1.5 M | Alliancebernstein L.p. | 2024-12-31 | 1.4 M | Vanguard Group Inc | 2024-12-31 | 14.5 M | Blackrock Inc | 2024-12-31 | 13.2 M |
Follow Synopsys' market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 69 B.Market Cap |
|
Project Synopsys' profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.22 | 0.23 | |
Return On Capital Employed | 0.15 | 0.14 | |
Return On Assets | 0.20 | 0.21 | |
Return On Equity | 0.29 | 0.30 |
When accessing Synopsys' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Synopsys' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Synopsys' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Synopsys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Synopsys. Check Synopsys' Beneish M Score to see the likelihood of Synopsys' management manipulating its earnings.
Evaluate Synopsys' management efficiency
Synopsys has return on total asset (ROA) of 0.0665 % which means that it generated a profit of $0.0665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1595 %, meaning that it created $0.1595 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Synopsys' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.21 in 2025, whereas Return On Capital Employed is likely to drop 0.14 in 2025. At this time, Synopsys' Return On Tangible Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.29 in 2025, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 53.03 | 55.68 | |
Tangible Book Value Per Share | 31.61 | 33.19 | |
Enterprise Value Over EBITDA | 50.08 | 52.59 | |
Price Book Value Ratio | 10.06 | 6.38 | |
Enterprise Value Multiple | 50.08 | 52.59 | |
Price Fair Value | 10.06 | 6.38 | |
Enterprise Value | 44.6 B | 46.9 B |
Effective leadership at Synopsys drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 10.8456 | Revenue | Quarterly Revenue Growth (0.04) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Synopsys insiders, such as employees or executives, is commonly permitted as long as it does not rely on Synopsys' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Synopsys insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Richard Mahoney over two weeks ago Disposition of 10322 shares by Richard Mahoney of Synopsys at 505.9868 subject to Rule 16b-3 | ||
De Geus Aart over six months ago Disposition of 186551 shares by De Geus Aart of Synopsys subject to Rule 16b-3 | ||
De Geus Aart over six months ago Disposition of 5448 shares by De Geus Aart of Synopsys at 89.76 subject to Rule 16b-3 | ||
De Geus Aart over six months ago Disposition of 4340 shares by De Geus Aart of Synopsys at 89.76 subject to Rule 16b-3 | ||
Richard Mahoney over six months ago Disposition of 3411 shares by Richard Mahoney of Synopsys at 590.21 subject to Rule 16b-3 | ||
De Geus Aart over six months ago Acquisition by De Geus Aart of 10938 shares of Synopsys at 567.06 subject to Rule 16b-3 | ||
Roy Vallee over a year ago Exercise or conversion by Roy Vallee of 6666 shares of Synopsys subject to Rule 16b-3 | ||
Roy Vallee over a year ago Acquisition by Roy Vallee of 464 shares of Synopsys subject to Rule 16b-3 |
Synopsys Corporate Filings
F4 | 10th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
5th of March 2025 Other Reports | ViewVerify | |
3rd of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Synopsys Earnings Estimation Breakdown
The calculation of Synopsys' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Synopsys is estimated to be 3.3997 with the future projection ranging from a low of 3.37 to a high of 3.44. Please be aware that this consensus of annual earnings estimates for Synopsys is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
3.37 Lowest | Expected EPS | 3.44 Highest |
Synopsys Earnings Projection Consensus
Suppose the current estimates of Synopsys' value are higher than the current market price of the Synopsys stock. In this case, investors may conclude that Synopsys is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Synopsys' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of April 2025 | Current EPS (TTM) | |
21 | 95.05% | 3.03 | 3.3997 | 8.3 |
Synopsys Earnings History
Earnings estimate consensus by Synopsys analysts from Wall Street is used by the market to judge Synopsys' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Synopsys' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Synopsys Quarterly Gross Profit |
|
Synopsys Earnings per Share Projection vs Actual
Actual Earning per Share of Synopsys refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Synopsys predict the company's earnings will be in the future. The higher the earnings per share of Synopsys, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Synopsys Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Synopsys, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Synopsys should always be considered in relation to other companies to make a more educated investment decision.Synopsys Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Synopsys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2025-02-19 | 2025-01-31 | 3.53 | 3.03 | -0.5 | 14 | ||
2024-12-04 | 2024-10-31 | 3.3 | 3.4 | 0.1 | 3 | ||
2024-08-21 | 2024-07-31 | 3.28 | 3.43 | 0.15 | 4 | ||
2024-05-22 | 2024-04-30 | 2.95 | 3.0 | 0.05 | 1 | ||
2024-02-21 | 2024-01-31 | 3.43 | 3.56 | 0.13 | 3 | ||
2023-11-29 | 2023-10-31 | 3.04 | 3.17 | 0.13 | 4 | ||
2023-08-16 | 2023-07-31 | 2.74 | 2.88 | 0.14 | 5 | ||
2023-05-17 | 2023-04-30 | 2.46 | 2.54 | 0.08 | 3 | ||
2023-02-15 | 2023-01-31 | 2.5 | 2.62 | 0.12 | 4 | ||
2022-11-30 | 2022-10-31 | 1.85 | 1.91 | 0.06 | 3 | ||
2022-08-17 | 2022-07-31 | 1.99 | 2.1 | 0.11 | 5 | ||
2022-05-18 | 2022-04-30 | 2.37 | 2.5 | 0.13 | 5 | ||
2022-02-16 | 2022-01-31 | 2.37 | 2.4 | 0.03 | 1 | ||
2021-12-01 | 2021-10-31 | 1.78 | 1.82 | 0.04 | 2 | ||
2021-08-18 | 2021-07-31 | 1.78 | 1.81 | 0.03 | 1 | ||
2021-05-19 | 2021-04-30 | 1.52 | 1.7 | 0.18 | 11 | ||
2021-02-17 | 2021-01-31 | 1.47 | 1.52 | 0.05 | 3 | ||
2020-12-02 | 2020-10-31 | 1.58 | 1.58 | 0.0 | 0 | ||
2020-08-19 | 2020-07-31 | 1.35 | 1.74 | 0.39 | 28 | ||
2020-05-20 | 2020-04-30 | 0.99 | 1.22 | 0.23 | 23 | ||
2020-02-19 | 2020-01-31 | 0.92 | 1.01 | 0.09 | 9 | ||
2019-12-04 | 2019-10-31 | 1.13 | 1.15 | 0.02 | 1 | ||
2019-08-21 | 2019-07-31 | 1.1 | 1.18 | 0.08 | 7 | ||
2019-05-22 | 2019-04-30 | 1.09 | 1.16 | 0.07 | 6 | ||
2019-02-20 | 2019-01-31 | 0.97 | 1.08 | 0.11 | 11 | ||
2018-12-05 | 2018-10-31 | 0.78 | 0.78 | 0.0 | 0 | ||
2018-08-22 | 2018-07-31 | 0.92 | 0.95 | 0.03 | 3 | ||
2018-05-23 | 2018-04-30 | 1.08 | 1.08 | 0.0 | 0 | ||
2018-02-21 | 2018-01-31 | 1 | 1.1 | 0.1 | 10 | ||
2017-11-29 | 2017-10-31 | 0.57 | 0.69 | 0.12 | 21 | ||
2017-08-16 | 2017-07-31 | 0.92 | 0.92 | 0.0 | 0 | ||
2017-05-17 | 2017-04-30 | 0.86 | 0.88 | 0.02 | 2 | ||
2017-02-15 | 2017-01-31 | 0.78 | 0.94 | 0.16 | 20 | ||
2016-11-30 | 2016-10-31 | 0.77 | 0.77 | 0.0 | 0 | ||
2016-08-17 | 2016-07-31 | 0.74 | 0.76 | 0.02 | 2 | ||
2016-05-18 | 2016-04-30 | 0.79 | 0.81 | 0.02 | 2 | ||
2016-02-17 | 2016-01-31 | 0.62 | 0.68 | 0.06 | 9 | ||
2015-12-02 | 2015-10-31 | 0.66 | 0.67 | 0.01 | 1 | ||
2015-08-19 | 2015-07-31 | 0.59 | 0.63 | 0.04 | 6 | ||
2015-05-20 | 2015-04-30 | 0.63 | 0.68 | 0.05 | 7 | ||
2015-02-18 | 2015-01-31 | 0.62 | 0.8 | 0.18 | 29 | ||
2014-12-03 | 2014-10-31 | 0.61 | 0.64 | 0.03 | 4 | ||
2014-08-20 | 2014-07-31 | 0.6 | 0.65 | 0.05 | 8 | ||
2014-05-21 | 2014-04-30 | 0.59 | 0.65 | 0.06 | 10 | ||
2014-02-19 | 2014-01-31 | 0.52 | 0.59 | 0.07 | 13 | ||
2013-12-04 | 2013-10-31 | 0.55 | 0.56 | 0.01 | 1 | ||
2013-08-21 | 2013-07-31 | 0.54 | 0.55 | 0.01 | 1 | ||
2013-05-22 | 2013-04-30 | 0.63 | 0.66 | 0.03 | 4 | ||
2013-02-20 | 2013-01-31 | 0.55 | 0.67 | 0.12 | 21 | ||
2012-12-05 | 2012-10-31 | 0.47 | 0.47 | 0.0 | 0 | ||
2012-08-22 | 2012-07-31 | 0.5 | 0.55 | 0.05 | 10 | ||
2012-05-23 | 2012-04-30 | 0.55 | 0.53 | -0.02 | 3 | ||
2012-02-22 | 2012-01-31 | 0.52 | 0.56 | 0.04 | 7 | ||
2011-11-30 | 2011-10-31 | 0.45 | 0.45 | 0.0 | 0 | ||
2011-08-17 | 2011-07-31 | 0.43 | 0.46 | 0.03 | 6 | ||
2011-05-18 | 2011-04-30 | 0.45 | 0.45 | 0.0 | 0 | ||
2011-02-16 | 2011-01-31 | 0.4 | 0.44 | 0.04 | 10 | ||
2010-12-01 | 2010-10-31 | 0.39 | 0.39 | 0.0 | 0 | ||
2010-08-18 | 2010-07-31 | 0.38 | 0.39 | 0.01 | 2 | ||
2010-05-19 | 2010-04-30 | 0.39 | 0.41 | 0.02 | 5 | ||
2010-02-17 | 2010-01-31 | 0.39 | 0.41 | 0.02 | 5 | ||
2009-12-02 | 2009-10-31 | 0.32 | 0.33 | 0.01 | 3 | ||
2009-08-19 | 2009-07-31 | 0.41 | 0.47 | 0.06 | 14 | ||
2009-05-20 | 2009-04-30 | 0.4 | 0.45 | 0.05 | 12 | ||
2009-02-18 | 2009-01-31 | 0.41 | 0.5 | 0.09 | 21 | ||
2008-12-03 | 2008-10-31 | 0.38 | 0.43 | 0.05 | 13 | ||
2008-08-20 | 2008-07-31 | 0.39 | 0.44 | 0.05 | 12 | ||
2008-05-21 | 2008-04-30 | 0.38 | 0.41 | 0.03 | 7 | ||
2008-02-20 | 2008-01-31 | 0.38 | 0.44 | 0.06 | 15 | ||
2007-12-06 | 2007-10-31 | 0.36 | 0.4 | 0.04 | 11 | ||
2007-08-22 | 2007-07-31 | 0.3 | 0.32 | 0.02 | 6 | ||
2007-05-23 | 2007-04-30 | 0.28 | 0.35 | 0.07 | 25 | ||
2007-02-21 | 2007-01-31 | 0.27 | 0.3 | 0.03 | 11 | ||
2006-11-29 | 2006-10-31 | 0.19 | 0.21 | 0.02 | 10 | ||
2006-08-16 | 2006-07-31 | 0.19 | 0.21 | 0.02 | 10 | ||
2006-05-17 | 2006-04-30 | 0.15 | 0.17 | 0.02 | 13 | ||
2006-02-15 | 2006-01-31 | 0.14 | 0.18 | 0.04 | 28 | ||
2005-11-30 | 2005-10-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2005-08-17 | 2005-07-31 | 0.08 | 0.1 | 0.02 | 25 | ||
2005-05-18 | 2005-04-30 | 0.09 | 0.09 | 0.0 | 0 | ||
2005-02-16 | 2005-01-31 | 0.06 | 0.1 | 0.04 | 66 | ||
2004-12-01 | 2004-10-31 | 0.03 | 0.01 | -0.02 | 66 | ||
2004-08-18 | 2004-07-31 | 0.32 | 0.33 | 0.01 | 3 | ||
2004-05-19 | 2004-04-30 | 0.33 | 0.35 | 0.02 | 6 | ||
2004-02-23 | 2004-01-31 | 0.31 | 0.33 | 0.02 | 6 | ||
2003-12-03 | 2003-10-31 | 0.42 | 0.44 | 0.02 | 4 | ||
2003-08-20 | 2003-07-31 | 0.4 | 0.41 | 0.01 | 2 | ||
2003-05-21 | 2003-04-30 | 0.35 | 0.4 | 0.05 | 14 | ||
2003-02-19 | 2003-01-31 | 0.32 | 0.34 | 0.02 | 6 | ||
2002-12-04 | 2002-10-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2002-08-21 | 2002-07-31 | 0.26 | 0.27 | 0.01 | 3 | ||
2002-06-04 | 2002-04-30 | 0.18 | 0.2 | 0.02 | 11 | ||
2002-02-20 | 2002-01-31 | 0.13 | 0.14 | 0.01 | 7 | ||
2001-12-03 | 2001-10-31 | 0.18 | 0.2 | 0.02 | 11 | ||
2001-08-22 | 2001-07-31 | 0.15 | 0.14 | -0.01 | 6 | ||
2001-05-23 | 2001-04-30 | 0.1 | 0.12 | 0.02 | 20 | ||
2001-01-26 | 2000-10-31 | -0.22 | 0.08 | 0.3 | 136 | ||
2000-08-16 | 2000-07-31 | 0.31 | 0.3 | -0.01 | 3 | ||
2000-05-18 | 2000-04-30 | 0.25 | 0.27 | 0.02 | 8 | ||
2000-02-17 | 2000-01-31 | 0.34 | 0.34 | 0.0 | 0 | ||
1999-10-26 | 1999-07-31 | 0.35 | 0.36 | 0.01 | 2 | ||
1999-07-27 | 1999-04-30 | 0.32 | 0.34 | 0.02 | 6 | ||
1999-04-22 | 1999-01-31 | 0.3 | 0.3 | 0.0 | 0 | ||
1999-01-20 | 1998-10-31 | 0.28 | 0.28 | 0.0 | 0 | ||
1998-10-27 | 1998-07-31 | 0.28 | 0.29 | 0.01 | 3 | ||
1998-07-21 | 1998-04-30 | 0.26 | 0.27 | 0.01 | 3 | ||
1998-04-27 | 1998-01-31 | 0.24 | 0.25 | 0.01 | 4 | ||
1998-01-29 | 1997-10-31 | 0.19 | 0.18 | -0.01 | 5 | ||
1997-10-21 | 1997-07-31 | 0.2 | 0.21 | 0.01 | 5 | ||
1997-07-17 | 1997-04-30 | 0.19 | 0.19 | 0.0 | 0 | ||
1997-04-17 | 1997-01-31 | 0.19 | 0.19 | 0.0 | 0 | ||
1997-01-20 | 1996-10-31 | 0.17 | 0.19 | 0.02 | 11 | ||
1996-10-22 | 1996-07-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1996-07-16 | 1996-04-30 | 0.15 | 0.15 | 0.0 | 0 | ||
1996-04-17 | 1996-01-31 | 0.14 | 0.14 | 0.0 | 0 |
Synopsys Corporate Management
Shankar Krishnamoorthy | Head Development | Profile | |
Paul Stravers | Principal Engineer | Profile | |
Shelagh Glaser | Chief Officer | Profile | |
Charlie Matar | Senior Group | Profile | |
John Koeter | Senior Strategy | Profile | |
John Runkel | General Counsel and Corporate Secretary | Profile |
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.